The potential value of peptide binding motifs of HLA class I molecules for the prediction of viral epitopes presented to T cells has been analyzed for HLA-A1 and -A3. CTL generated against type A influenza virus recognize peptide epitopes derived from the nucleoprotein (NP) and basic polymerase 1 presented by HLA-A1, and epitopes derived from NP presented by HLA-A3. Distinct peptide binding motifs with characteristic anchor residues were previously identified for each of these class 1 molecules based on the sequences of endogenous peptides. Six peptides containing the HLA-A1 binding motif were identified within the sequences of the NP and basic polymerase 1 proteins, and one peptide containing the HLA-A3 motif was identified in the NP molecule. Two of the HLA-A1 binding peptides could sensitize target cells for lysis by influenza virus-immune CTL populations restricted by HLA-A1 and the one HLA-A3 NP peptide (NP 265-273 ILRGSVAHK) could sensitize target cells for lysis by HLA-A3 restricted influenza-immune CTL. Each peptide was also shown to be able to induce peptide-specific class I-restricted CTL in vitro, and the CTL generated against two of these peptides could specifically recognize virus-infected targets. Thus, peptide binding motifs can be used to construct immunogenic synthetic epitopes which are capable of inducing antiviral T cell-mediated immune responses. Distinct amino acid residue motifs for peptides binding to HLA-A1 and HLA-B8 were identified by sequence analyses of reversed-phase HPLC fractions containing endogenous peptides derived from these HLA molecules. Fifteen different primary sequences were determined for HLA- A1 associated peptides. Common features among these peptide sequences were Tyr at the C-terminus, a negatively charged aa (usually Glu) at position 3 (P3), and pro at P4. Twenty-seven different primary sequence assignments were made for HLA-B8 associated peptides, most of which were eight aa in length. Lys, and in a few cases Arg, predominated at P3 and P5; Leu and Pro predominated at P2, and Leu was the preferred COOH- terminal residue. Eight of the HLA-A1 and HLA-B8 endogenous peptide sequences matched intracellularly expressed proteins found in protein sequence data bases. The HLA-A1 peptide-binding motif was then used to identify potential antigenic peptides from influenza A viral proteins that bound to HLA-A1 in vitro.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000543-07
Application #
3746573
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
1994
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Burgess, Steven J; Marusina, Alina I; Pathmanathan, Ishani et al. (2006) IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells. J Immunol 176:1490-7
Lieto, L D; Maasho, K; West, D et al. (2006) The human CD94 gene encodes multiple, expressible transcripts including a new partner of NKG2A/B. Genes Immun 7:36-43
Marusina, Alina I; Kim, Dae-Ki; Lieto, Louis D et al. (2005) GATA-3 is an important transcription factor for regulating human NKG2A gene expression. J Immunol 174:2152-9
Borrego, Francisco; Masilamani, Madhan; Kabat, Juraj et al. (2005) The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor. Mol Immunol 42:485-8
Maasho, Kerima; Marusina, Alina; Reynolds, Nicole M et al. (2004) Efficient gene transfer into the human natural killer cell line, NKL, using the Amaxa nucleofection system. J Immunol Methods 284:133-40
Kim, Dae-Ki; Kabat, Juraj; Borrego, Francisco et al. (2004) Human NKG2F is expressed and can associate with DAP12. Mol Immunol 41:53-62
Sanni, Tolib B; Masilamani, Madhan; Kabat, Juraj et al. (2004) Exclusion of lipid rafts and decreased mobility of CD94/NKG2A receptors at the inhibitory NK cell synapse. Mol Biol Cell 15:3210-23
Lieto, Louis D; Borrego, Francisco; You, Chi-Hyun et al. (2003) Human CD94 gene expression: dual promoters differing in responsiveness to IL-2 or IL-15. J Immunol 171:5277-86
Borrego, Francisco; Kabat, Juraj; Sanni, Tolib B et al. (2002) NK cell CD94/NKG2A inhibitory receptors are internalized and recycle independently of inhibitory signaling processes. J Immunol 169:6102-11
Kabat, Juraj; Borrego, Francisco; Brooks, Andrew et al. (2002) Role that each NKG2A immunoreceptor tyrosine-based inhibitory motif plays in mediating the human CD94/NKG2A inhibitory signal. J Immunol 169:1948-58

Showing the most recent 10 out of 11 publications